Intrexon | XON - Trade Creditors


Intrexon reported $4.85M in Trade Creditors for its fiscal quarter ending in June of 2024.





Trade Creditors Change Date
Agenus USD 71.08M 11.9M Mar/2026
Alaunos Therapeutics USD 400K 213K Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
Anika Therapeutics USD 6.34M 298K Mar/2026
Arrowhead Research USD 30.75M 2.19M Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Heron Therapeutics USD 8.97M 24K Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Intrexon USD 4.85M 3.12M Jun/2024
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Ligand Pharmaceuticals USD 37.11M 33.87M Mar/2026
MacroGenics USD 4.29M 500K Mar/2026
MannKind USD 16.14M 7.11M Mar/2026
Merck USD 3.86B 541M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Thermo Fisher Scientific USD 3.34B 278M Mar/2026
Veracyte USD 6.91M 2.32M Mar/2026
Xencor USD 7.92M 2.91M Mar/2026